Journal Mobile Options
Table of Contents
Vol. 80, No. 1, 2004
Issue release date: 2004
Neuroendocrinology 2004;80:21–30

Bisphenol A Exerts Thyroid-Hormone-Like Effects on Mouse Oligodendrocyte Precursor Cells

Seiwa C. · Nakahara J. · Komiyama T. · Katsu Y. · Iguchi T. · Asou H.
aGlial Cell Research Group, Tokyo Metropolitan Institute of Gerontology; bCenter for Bioscience, Okazaki National Research Institutes, Okazaki; cCREST, Kawaguchi, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


We report studies on the mechanism of action of bisphenol A (BPA) on the differentiation of oligodendrocyte precursor cells (OPCs). Our results show that: (1) BPA inhibits the differentiation of OPCs induced by exposure to thyroid hormone (T3). (2) The effect is mediated through various mechanisms via the thyroid hormone receptor (TRβ1) which is considered to be responsible for OPC differentiation. (3) The action of BPA on OPC differentiation does not involve the FcRγ-Fyn-myelin basic protein (MBP) cascade as an inducer of OPC differentiation nor does it suppress CREB phosphorylation, which is considered to be induced by the T3-TR complex. (4) The presence of MBP isoforms (21.5, 18.5, 17.0 and 14.0 kDa) was detected in OPCs, and the expression of exon 2-containing isoforms (i.e. 17.0 and 21.5 kDa) was upregulated upon treatment with T3. In contrast, expression of MBP was inhibited by BPA.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Hardy R, Reynolds R: Proliferation and differentiation potential of rat forebrain oligodendroglial progenitors both in vitro and in vivo. Development 1991;111:1061–1080.
  2. Levison SW, Goldman JE: Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron 1993;10:201–212.
  3. Zerlin M, Levison SW, Goldman JE: Early patterns of migration, morphogenesis, and intermediate filament expression of subventricular zone cells in the postnatal rat forebrain. J Neurosci 1995;15:7238–7249.
  4. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC: Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992;70:31–46.
  5. Barres BA, Schmid R, Sendnter M, Raff MC: Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993;118:283–295.
  6. Barres BA, Raff MC, Gaese F, Bartke I, Dechant G, Barde YA: A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 1994;367:371–375.
  7. Knipper M, Bandtlow C, Gestwa L, Kopschall I, Rohbock K, Wiechers B, Zenner HP, Zimmermann U: Thyroid hormone affects Schwann cell and oligodendrocyte gene expression at the glial transition zone of the VIIIth nerve prior to cochlea function. Development 1998;125:3709–3718.
  8. Billon N, Tokumoto Y, Forrest D, Raff M: Role of thyroid hormone receptors in timing oligodendrocyte differentiation. Dev Biol 2001;235:110–120.
  9. Toran-Allerand CD: On the genesis of sexual differentiation of the general nervous system: Morphogenetic consequences of steroidal exposure and possible role of alpha-fetoprotein. Prog Brain Res 1984;61:63–98.
  10. Garcia-Segura LM, Suarez I, Segovia S, Tranque PA, Cales JM, Aguilera P, Olmos G, Guillamon A: The distribution of glial fibrillary acidic protein in the adult rat brain is influenced by the neonatal levels of sex steroids. Brain Res 1988;456:357–363.
  11. Matsumoto A, Arai Y: Neuronal plasticity in the deafferented hypothalamic arcuate nucleus of adult female rats and its enhancement by treatment with estrogen. J Comp Neurol 1981;197:197–205.
  12. Wang S, Sdrulla A, Johnson JE, Yokota Y, Barres BA: A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development. Neuron 2001;29:603–614.
  13. Wang L, Andersson S, Warner M, Gustafsson JA: Estrogen receptor (ER) beta knockout mice reveal a role for ER beta in migration of cortical neurons in the developing brain. Proc Natl Acad Sci USA 2003;100:703–708.
  14. Seiwa C, Kojima-Aikawa K, Matsumoto I, Asou H: CNS myelinogenesis in vitro: Myelin basic protein deficient shiverer oligodendrocytes. J Neurosci Res 2002;69:305–317.
  15. Raff MC, Abney ER, Cohen J, Lindsay R, Noble M: Two types of astrocytes in cultures of developing rat white matter. J Neurosci 1983;3:1289–1300.
  16. Nishiyama A, Chang A, Trapp BD: NG2+ glial cells: A novel glial cell population in the adult brain. J Neuropathol Exp Neurol. 1999;58:1113–1124.
  17. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
  18. Nakahara J, Tan-Takeuchi K, Seiwa C, Gotoh M, Kaifu T, Ujike A, Inui M, Yagi T, Ogawa M, Aiso S, Takai T, Asou H: Signaling via immunoglobulin Fc receptors induces oligodendrocyte precursor cell differentiation. Dev Cell 2003;4:841–852.
  19. Gao FB, Apperly J, Raff M: Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells. Dev Biol 1998;197:54–66.
  20. Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD, Rowitch DH: Sonic hedgehog–regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 2000;25:317–329.
  21. Yen PM. Physiological and molecular basis of thyroid hormone action: Physiol Rev 2001;81:1097–1142.
  22. Ahlgren SC, Wallace H, Bishop J, Neophytou C, Raff MC: Effects of thyroid hormone on embryonic oligodendrocyte precursor cell development in vivo and in vitro. Mol Cell Neurosci 1997; 9:420–432.
  23. Kondo T, Raff M: Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation. Development 2000;127:2989–2998.
  24. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamato N, Hataya Y, Shimatsu A, Kuzuya H, Nakao K: Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 2002;87:5185–5190.
  25. de Ferra F, Engh H, Hudson L, Kamholz J, Puckett C, Molineaux S, Lazzarini RA: Alternative splicing accounts for the four forms of myelin basic protein. Cell 1985;43:721–727.
  26. Barbarese E, Carson JH, Braun PE: Accumulation of the four myelin basic proteins in mouse brain during development. J Neurochem 1978;31:779–782.
  27. Carson JH, Nielson ML, Barbarese E: Developmental regulation of myelin basic protein expression in mouse brain. Dev Biol 1983;96:485–492.
  28. Farsetti A, Mitsuhashi T, Desevergne B, Robbins J, Nikodem VM: Molecular basis of thyroid hormone regulation of myelin basic proten gene expression in rodent brain. J. Biol Chem 1991;266:23226–23232.
  29. Afshari FS, Chu AK, Sato-Bigbee C: Recovery of adult oligodendrocytes is preceded by a ‘lag period’ accompanied by upregulation of transcription factors expressed in developing young cells. J Neurosci Res 2002;67:174–184.
  30. Mendez-Pertuz M, Sanchez-Pacheco A, Aranda A: The thyroid hormone receptor antagonizes CREB-mediated transcription. EMBO J 2003;22:3102–3112.
  31. Schwartz HL, Ross ME, Oppenheimer JH: Lack of effect of thyroid hormone on late fetal rat brain development. Endocrinology 1997;138:3119–3124.
  32. Carre JL, Demerens C, Rodriguez-Pena A, Floch HH, Vincendon G, Sarlieve LL: Thyroid hormone receptor isoforms are sequentially expressed in oligodendrocyte lineage cells during rat cerebral development. J Neurosci Res 1998;54:584–594.
  33. Walravens P, Chase HP: Influence of thyroid on formation of myelin lipids. J Neurochem 1969;16:1477–1484.
  34. Pfeiffer SE, Warrington AE, Bansal R: Oligodendrocyte and its many cellular processes. Trends Neurosci 1993;3:191–198.
  35. Ludwin SK: An autoradiographic study of cellular proliferation in remyelination of the central nervous system. Am J Pathol 1979;95:683–696.
  36. Chang A, Tourtellotte WW, Rudick R, Trapp BD: Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002;346:165–173.
  37. Lubetzki C, Goujet-Zalc C, Demerens C, Danos O, Zalc B: Clonal segregation of oligodendrocytes and astrocytes during in vitro differentiation of glial progenitor cells. Glia 1992;6:289–300.
  38. Kipp JL, Ramirez VD: Estradiol and testosterone have opposite effects on microtubule polymerization. Neuroendocrinology 2003; 77:258–272.
  39. Baas D, Fressinaud C, Ittel ME, Reeber A, Dalencon D, Puymirat J, Sarlieve LL: Expression of thyroid hormone receptor isoforms in rat oligodendrocyte cultures. Effect of 3,5,3′-triiodo-L-thyronine. Neurosci Lett 1994;176:47–51.
  40. Billon N, Jolicoeur C, Tokumoto Y, Vennstrom B, Raff M: Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha (TR α1). EMBO J 2002;21:6452–6460.
  41. Huo B, Dozin B, Nikodem VM: Identification of a nuclear protein from rat developing brain as heterodimerization partner with thyroid hormone receptor-beta. Endocrinology 1997;138:3283–3289.
  42. Sato-Bigbee C, Chan EL, Yu RK: Oligodendroglial cyclic AMP response element-binding protein: A member of the CREB family of transcription factors. J Neurosci Res 1994;38:621–628.
  43. Farsetti A, Desvergne B, Hallenbeck P, Robbins J, Nikodem VM: Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter. J Biol Chem 1992;267:15784–15788.
  44. Tosic M, Torch S, Comte V, Dolivo M, Honegger P, Matthieu JM: Triiodothyronine has diverse and multiple stimulating effects on expression of the major myelin protein genes. Neurochemistry 1992;59:1770–1777.
  45. Puymirat J, l’Hereault S, Dussault JH: Expression of thyroid hormone receptor mRNAs in rat cerebral hemisphere neuronal cultures. Brain Res Dev Brain Res 1992;69:173–177.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50